Impact of Bronchopulmonary Dysplasia on Families Quality of Life A Study of Parents and Caregivers of Preterm Children Under 18
Led by Global Foundation for the Care of Newborn Infants · Updated on 2025-11-21
480
Participants Needed
1
Research Sites
47 weeks
Total Duration
AI-Summary
What this Trial Is About
This research aims to examine the long-term effects on parents and caregivers of children diagnosed with Bronchopulmonary Dysplasia BPD as newborns. The study focuses on families of children under 18 years old who were born preterm. Data will be collected through an online questionnaire from participants in France, Germany, Italy, the Netherlands, Spain, the United Kingdom, and the United States. The goal is to understand the impact of BPD on caregivers quality of life, health literacy, support systems, and the economic burden on families.
The study is observational and uses a cross-sectional design with a comparison group. Participants will answer a self-administered web-based survey available in multiple languages. The survey asks about caregiver and child background, medical history including lung problems, parental quality of life, and financial costs. Parents or caregivers of children with BPD and those of preterm children without BPD will be compared. The questionnaire avoids using the term BPD for clarity and is developed with input from expert groups and parent representatives.
Participants will complete the online questionnaire between September 2025 and February 2026. Researchers will assess parental health-related quality of life using the Pediatric Quality of Life Inventory Family Impact Module, along with questions on the childs medical condition, family economic burden, health literacy, and available support. The study is designed to provide insight into the long-term challenges faced by families affected by BPD and to inform future support strategies.
CONDITIONS
Brief Title
Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)
Research Team
C
Christina Tischer, Dr
J
Julia Feiler, Dr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Being a parent or primary caregiver of a child under 18 years old
Child was born preterm before 37 weeks of gestation
Child has been discharged from their initial hospital stay after birth
Child was diagnosed with BPD in the newborn period (for BPD group)
Child did not suffer from BPD in the newborn period (for control group)
Child was born or currently lives in France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland), or the United States
Providing sufficient proficiency in one of the questionnaire languages
You will not qualify if you...
Being other family members than parents or primary caregivers
Parent or caregiver of a child 18 years or older
Parent or caregiver of a child with BPD who has not been discharged yet (for BPD group)
Parent or caregiver of a child without BPD who has not been discharged yet (for control group)
Parent or caregiver of a child born at term (for control group)
Insufficient proficiency in one of the questionnaire languages
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Survey Completion
Duration - Variable, based on participant response time
Participants complete a self-administered, web-based questionnaire to provide information about their child's medical history, their own health-related quality of life, health literacy, support structures, and economic burden related to bronchopulmonary dysplasia (BPD).
1 online questionnaire completion
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Study of Extracellular Vesicles in Umbilical Cord Blood of Extremely Premature Newborns Born Before 28 Weeks and Their Link to Severe Health Problems
Observational Study on Chloride Levels and Their Impact on Lung Disease and Survival in Premature Infants Born Before 32 Weeks or Weighing Under 1500 Grams
Comparing Continued CPAP Use Versus Nasal Cannula to Prevent Lung Problems or Death in Premature Infants
Randomized Trial of Enteral ARA and DHA Supplementation to Prevent Bronchopulmonary Dysplasia in Extremely and Very Preterm Infants at Aristotle University of Thessaloniki
Evaluating Quality of Life in Children Aged 2 to 15 with Clubfoot Treated by the Ponseti Method
A 5-Year Observational Study at Drammen Hospital
Impact of Bronchopulmonary Dysplasia on Families Quality of Life A Study of Parents and Caregivers of Preterm Children Under 18
Study of Metformin to Help Premature Infants With Bronchopulmonary Dysplasia
Testing Safety and Tolerance in Different Age Groups
Safety and Pharmacokinetics of Montelukast in Premature Infants with Developing Bronchopulmonary Dysplasia
Randomized, Placebo-Controlled Study of Montelukast in Critically Ill Preterm Infants
Lung Volume Changes in Preterm Infants Using Synchronized Noninvasive Positive Pressure Ventilation
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
BronQ Family: assessing the long-term impact of Bronchopulmonary Dysplasia on affected families' health-related quality of life - protocol of a multi-country study.